Event-Driven Stocks

TIANYIN PHARMACEUTICAL CO., INC.

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

Signs● 5 good● 2 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY14FY13FY12FY11
Revenue$46.6M$67.5M$69.6M$95.2M
Operating income$2.7M$9.3M$8.5M$18.1M
Net income−$644,952$6.7M$6.4M$15.7M
Total assets$106.9M$110.1M$104.3M$90.2M
Total liabilities$9.1M$11.9M$14.8M$8.9M
Equity$97.7M$98.0M$89.2M$80.8M
EPS (diluted)—$0.23$0.22$0.53
Shares out.29.4M29.4M29.3M29.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2014
Operating margin
5.8%
Net margin
−1.4%
Return on equity
−0.7%
Return on assets
−0.6%
Return on capital (ROCE)
2.7%
Liabilities / assets
8.5%
Debt / equity
0.09×
Book value / share
$3.32
Revenue growth (YoY)
−31.0%
Net income growth (YoY)
−109.7%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2014
Altman Z″ (distress)
14.45safe
Accruals / assets
−2.9%clean
Beneish M-Score
-2.42normal
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
61
/ 100
Profitability 40Growth 0Catalyst 67Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 2 warning● 5 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Reported a net loss
  • Revenue declined year-over-year
  • Operating margin is positive
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Insider transactions

SEC Form 4 · most recent
1 acquisitions0 disposals1 open-market buy(s)net +2,930 shares · last 1
InsiderDateTypeSharesPrice
Tong James JiayuanOfficer — CFO &amp; Director &amp; CBDOMay 28, 2014Buy2,930$0.75

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)